Accéder au contenu
Merck
Toutes les photos(1)

Documents

P6617

Sigma-Aldrich

Pristanic acid

≥97% (GC), ethanol solution

Synonyme(s) :

2,6,10,14-Tetramethylpentadecanoic acid

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C19H38O2
Numéro CAS:
1189-37-3
Poids moléculaire :
298.50
Numéro CE :
200-578-6
Numéro MDL:
MFCD05664739
Code UNSPSC :
12352106
ID de substance PubChem :
329820250
Nomenclature NACRES :
NA.77

product name

Pristanic acid solution, mixture of isomers, ethanol solution, ≥97% (GC)

Niveau de qualité

200

Pureté

≥97% (GC)

Forme

ethanol solution

Température de stockage

−20°C

Chaîne SMILES 

CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O

InChI

1S/C19H38O2/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19(20)21/h15-18H,6-14H2,1-5H3,(H,20,21)

Clé InChI

PAHGJZDQXIOYTH-UHFFFAOYSA-N

Actions biochimiques/physiologiques

Oxidation product of fatty acids in the diet, particularly phytanic acid. Phytanic acid is oxidized by alpha oxidation yielding pristanic acid, which is subsequently degraded by peroxisomal beta oxidation. Several inborn errors of metabolism with one or more deficiencies in the phytanic acid and pristanic acid breakdown have been described.

Pictogrammes

FlameExclamation mark
GHS02,GHS07

Mention d'avertissement

Danger

Mentions de danger

H225,H319

Classification des risques

Eye Irrit. 2 - Flam. Liq. 2

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

55.4 °F

Point d'éclair (°C)

13 °C

Équipement de protection individuelle

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 7

1 of 7

Acide elaidique ≥99.0% (GC)

Sigma-Aldrich

E4637

Acide elaidique

Acide erucique ≥99% (capillary GC)

Sigma-Aldrich

E3385

Acide erucique

Acide behenique analytical standard

Supelco

11909

Acide behenique

Acide erucique analytical standard

Supelco

45629

Acide erucique

Acide palmitoleique ≥98.5% (GC), liquid

Sigma-Aldrich

P9417

Acide palmitoleique

Huile de paraffine puriss., meets analytical specification of Ph. Eur., BP, viscous liquid

Sigma-Aldrich

18512

Huile de paraffine

Acide oléique ≥99% (GC)

Sigma-Aldrich

O1008

Acide oléique

Antonella Peduto et al.
Molecular genetics and metabolism, 82(3), 224-230 (2004-07-06)
Peroxisomal disorders include a complex spectrum of diseases, characterized by a high heterogeneity from both the clinical and the biochemical points of view. Specific assays are required for the study of peroxisome metabolism. Among these, pipecolic acid evaluation is considered
D S Roe et al.
Molecular genetics and metabolism, 87(1), 40-47 (2005-11-22)
The differentiation of carnitine-acylcarnitine translocase deficiency (CACT) from carnitine palmitoyltransferase type II deficiency (CPT-II) and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency from mitochondrial trifunctional protein deficiency (MTP) continues to be ambiguous using current acylcarnitine profiling techniques either from plasma or blood
James A Mobley et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 12(8), 775-783 (2003-08-15)
An enzyme previously identified as alpha-methylacyl-CoA racemase (AMACR) is overexpressed in high-grade prostatic intraepithelial neoplasia and in a majority (60-100%) of prostate cancers (CaPs) as compared with normal and benign hyperplastic lesions of the prostate, where it is minimally expressed.
J Gootjes et al.
Neurology, 59(11), 1746-1749 (2002-12-11)
To identify prognostic markers reflecting the extent of peroxisome dysfunction in primary skin fibroblasts from patients with peroxisome biogenesis disorders (PBD). PBD are a genetically heterogeneous group of disorders due to defects in at least 11 distinct genes. Zellweger syndrome
Biochemical markers predicting survival in peroxisome biogenesis disorders.
Jeannette Gootjes et al.
Advances in experimental medicine and biology, 544, 67-68 (2004-01-10)
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique